11.200
+0,00%
2026-10-07
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -41.9% | +6.4% | 2 / 3 | +8.5% | -5.15 pp | -7.64 pp | +8.8% | 0.09 | 10.90 | 72,0 | +8,5% | 6,3 | −41,9% | 10.90 | 12.45 | −12,5% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 11.200 (close price on 2026-10-07)EPS (TTM): 1.028
Financial charts
1.Revenue & growth
VND bn72,1Q2/26
1.Revenue & growth
VND bn72,1Q2/26
2.Profit & growth
VND bn6,40Q2/26
3.Profit mix (Penman)
VND bn26,8Q2/26
4.Margins & cost structure
%25.0%Q2/26
5.Returns & cash cycle
% · days7.5%Q2/26
6.Earnings quality & cash
VND bn38,5Q2/26
7.Asset structure
VND bn312Q2/26
8.Funding & debt health
VND bn · times312Q2/26
9.Revenue backlog
VND bn0,60Q2/26
10.Valuation
times · %10,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %297Q2/26
Adjusted EPS growth, latest quarter
-41.4%
Average adjusted EPS growth, 3 quarters
6.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26